Tracking a year of arthritis treatment: can patients stick with it?
NCT ID NCT06247722
Summary
This study is observing 600 people with moderate-to-severe rheumatoid arthritis who are already prescribed a medication called Tyenne. The main goal is to see how many patients continue taking this drug for 6 and 12 months in real-world doctor's offices, not a controlled trial. Researchers will also track changes in patients' arthritis symptoms and overall health over the year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Facharztpraxis für Innere Medizin
Naumburg, 06618, Germany
-
Facharztpraxis für Innere Medizin Ludwigsfelde
Ludwigsfelde, 14974, Germany
-
Klinische Forschung
Planegg, 82152, Germany
-
Rheumahaus Potsdam
Potsdam, 14467, Germany
-
Rheumapraxis Dr. Liebhaber Halle
Halle, 06128, Germany
-
Rheumatologische Facharztpraxis
Magdeburg, 39104, Germany
-
Rheumatologische Facharztpraxis Templin
Templin, 17268, Germany
-
Rheumatologische Schwerpunktpraxis Berlin
Berlin, 12161, Germany
Conditions
Explore the condition pages connected to this study.